Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in Thailand

Conclusions
In this context, treatment of severe cases with meropenem is likely to be cost-effective, while the evidence to support the use of meropenem in non-severe suspected melioidosis is not yet available.

Source: Transactions of the Royal Society of Tropical Medicine and Hygiene - May 20, 2015 Category: Tropical Medicine Authors: Hantrakun, V., Chierakul, W., Chetchotisakd, P., Anunnatsiri, S., Currie, B. J., Peacock, S. J., Day, N. P. J., Cheah, P., Limmathurotsakul, D., Lubell, Y. Tags: SHORT COMMUNICATION Source Type: research